Magovcevic-Liebisch Ivana — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Magovcevic-Liebisch Ivana has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $28K. Historical track record: 3/5 stars across 3 tracked purchases.

Profile

Magovcevic-Liebisch Ivana

Ivana Magovcevic-Liebisch is a corporate executive known for her roles as President and CEO at Acrivon Therapeutics, Inc. and other biotechnology firms. She has significant experience in the life sciences sector, contributing to the advancement of therapeutic innovations.

RoleInsider
Notability30/100

Board memberships

Awards & honors

Track Record

InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.

InsiderAlpha rating★★★☆☆ (3/5)
Total purchases tracked3
Purchases with forward-return data3
30-day win rate6667%
90-day win rate10000%
Avg 5-day return-288.24%
Avg 30-day return+673.10%
Avg 90-day return+1275.21%
Best 30-day return+2530.12%

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-05-20ACRVAcrivon Therapeutics, Inc.A — Grant or award9.4K$0.00
2026-01-15QTRXQuanterix CorpA — Grant or award23.4K$0.00
2025-08-05VIGLVigil Neuroscience, Inc.D — Derivative transaction222.7K
2024-12-19VIGLVigil Neuroscience, Inc.P — Open-market purchase5.0K$1.68$8K
2024-12-18VIGLVigil Neuroscience, Inc.P — Open-market purchase5.0K$1.67$8K
2024-12-05VIGLVigil Neuroscience, Inc.P — Open-market purchase5.0K$2.34$12K
2024-10-03QTRXQuanterix CorpA — Grant or award12.8K$0.00

Companies — Last 90 Days

Frequently Asked Questions

Who is Magovcevic-Liebisch Ivana?

Ivana Magovcevic-Liebisch is a corporate executive known for her roles as President and CEO at Acrivon Therapeutics, Inc. and other biotechnology firms. She has significant experience in the life sciences sector, contributing to the advancement of therapeutic innovations.…

How many SEC Form 4 filings has Magovcevic-Liebisch Ivana submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Magovcevic-Liebisch Ivana been buying or selling stock?

Recorded transactions: 3 open-market purchases ($28K) and 0 open-market sales () across all tracked filings.

How accurate is Magovcevic-Liebisch Ivana's historical track record?

Across 3 tracked purchases, Magovcevic-Liebisch Ivana averaged +673.1% avg 30-day return with a 6667% 30-day win rate. InsiderAlpha rates the track record at 3/5 stars.

Where can I see all of Magovcevic-Liebisch Ivana's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Magovcevic-Liebisch Ivana profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.